ColoAd1-1003: A Phase I Multicenter, Open Label Study of Enadenotucirev Combined With PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

February 18, 2019
Cancer - Colorectal, Cancer - Bladder, Cancer - Head and Neck
Principal Investigator: Ding Wang, MD
Cancer, Phase I, Phase 1, epithelial tumors, advanced epithelial tumors, metastatic, colorectal cancer, colorectal, bladder, Head and Neck